eNewsletter


< Back

China Market Watch (Dec 2021)

2021-12-31

1. China’s Provisions on the Supervision and Administration of Children's Cosmetics Come into Force on 1 January 2022

 

To strengthen the supervision and administration of children’s cosmetics and ensure the safety of children’s usage of cosmetics, in accordance with the Regulations on the Supervision and Administration of Cosmetics and other laws and regulations, the China National Medical Products Administration had developed and announced the Provisions on the Supervision and Administration of Children's Cosmetics (the Provisions).  The gazette regarding the implementation of the Provisions is as follows:

 

a) Apart from the requirement of labels, all other provisions regarding children's cosmetics will come into force on 1 January 2022.

 

b) Starting from 1 May 2022, registrars or recordation of children's cosmetics must comply with the product labelling in accordance with the Provisions.  The registration or recordation prior to 1 May 2022, but not yet labelled as stated in the Provisions, they should complete the updates before 1 May 2023, in order to comply with the Provisions.

 

c) The children’s cosmetics labelling will be announced in due course.

 

STC laboratories have obtained the qualification of China’s food and cosmetics recordation and testing.  We can issue test reports used in product registration and recordation.  For more details, please email us at hkstc@stc.group.

 

Source:  https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20211008171226187.html

 

2. GACC Announced New Scope for Conducting Random Inspections of Imported and Exported Commodities Other than Those Subject to the Statutory Inspection

 

According to the Law of the People's Republic of China on the Inspection of Imported and Exported Commodities and its Implementation Regulation, the General Administration of Customs (GACC) decided to conduct random inspections for some imported and exported commodities other than those subject to the statutory inspection starting from the date of the announcement.  The scope of commodities is as follows:

 

  • Imported commodities:  dishwashers, air purifiers, electronic toilets, food waste processors, induction cookers, printers, stationeries, accessories, automobile parts and components, apparels, helmets, children’s car seats, paper or paper plates, paper trays, paper cups or similar products, and so on.
  • Exported commodities:  festive lights, LED lighting sources, children’s bicycles, children’s scooters, children’s vehicles, toys, food contact plastic wares and so on.

 

The cost of the random inspection is borne by the GACC while enterprises have to cooperate.  For more details on product compliance of different countries, please contact us at dgstc@stc.group.

 

Source:  http://www.customs.gov.cn/customs/302249/302266/302267/3817175/index.html

 

3. Recordation of Traditional Chinese Medicine Formula Granules Varieties after Pilot Run

 

Relevant ministries and commissions of China jointly issued the Announcement on Ending the Pilot Scheme of Traditional Chinese Medicine Formula Granules (the Announcement), which confirmed the end of the pilot scheme of traditional Chinese medicine formula granules, and the recordation for the formula granules varieties.  The quality control of the varieties will be included in the administrative scope of traditional Chinese medicine decoction pieces.  Based on the Announcement, all provinces (autonomous regions, and cities) successively published the provincial level of the measures for the administration of traditional Chinese medicine formula granules and related documents.  As of 3 November 2021, 26 provinces (autonomous regions, and cities) had already published related documents, in order to continuously strengthen product quality after the pilot run.

 

According to the Chinese Medicine Ordinance of Hong Kong, all proprietary Chinese medicines must be registered before they are imported to, manufactured or distributed in Hong Kong.  STC’s pharmaceutical laboratory is recognized by the Hong Kong Government to issue test reports that can be used in proprietary Chinese medicines registration.  For more details regarding proprietary Chinese medicines testing and registration services, please contact us at hkstc@stc.group.

 

Source:  https://mp.weixin.qq.com/s/sOyrL-LnMxq0RzsuPquUfA

 

4. China Issued the Operating Rules for the Registration and Approval of Class III Domestic and Imported Medical Devices

 

To implement the requirement of the Regulation on the Supervision and Administration of Medical Devices (Order No. 739 of the State Council), in accordance with the Measures for the Administration of Registration and Recordation of Medical Devices and the Measures for the Administration of Registration and Recordation of In-Vitro Diagnostic Reagents (Order No. 47 and 48 of theState Administration for Market Regulation), the State Food and Drug Administration revised the Operating Rules for the Registration and Approval of Class III Domestic and Imported Medical Devices, and hereby issued, which should be implemented since 2 November 2021.  Simultaneously, the Notice of the China Food and Drug Administration on Matters concerning Issuing the Operating Rules for the Registration and Approval of Class III Domestic and Imported Medical Devices (No. 208 [2014] of the China Food and Drug Administration) was abolished.

 

Source:  https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjylqx/20211104141907123.html

 

[See PDF version for more information]

 

Contact us for details.